project id: TCGA-HNSC; case submitter id: TCGA-RS-A6TP; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.89; rna integrity number: 9.2; age at index: 58; days to birth: -21393; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 21393; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 516.0; icd 10 code: C09.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tonsil, NOS; synchronous malignancy: No; tissue or organ of origin: Tonsil, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 117; days to sample procurement: 0; initial weight: 400.0; portion submitter id: TCGA-RS-A6TP-01A-12; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0;